Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis

[1]  J. Rinne,et al.  In Vivo PET Imaging Demonstrates Diminished Microglial Activation After Fingolimod Treatment in an Animal Model of Multiple Sclerosis , 2015, The Journal of Nuclear Medicine.

[2]  S. Jalkanen,et al.  68Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections , 2014, EJNMMI Research.

[3]  J. Parratt,et al.  Oligodendrocytes and the early multiple sclerosis lesion , 2012, Annals of neurology.

[4]  H. Elovaara,et al.  Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer. , 2011, Blood.

[5]  A. Prat,et al.  Disruption of central nervous system barriers in multiple sclerosis. , 2011, Biochimica et biophysica acta.

[6]  P. Mishra,et al.  MRI in Rodent Models of Brain Disorders , 2011, Neurotherapeutics.

[7]  Frauke Zipp,et al.  Multiple sclerosis – candidate mechanisms underlying CNS atrophy , 2010, Trends in Neurosciences.

[8]  S. Jalkanen,et al.  Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. , 2009, Blood.

[9]  N. Sibson,et al.  Comparison of MRI signatures in pattern I and II multiple sclerosis models , 2009, NMR in biomedicine.

[10]  Willi Kalender,et al.  In vivo micro-CT imaging of rat brain glioma: A comparison with 3T MRI and histology , 2009, Neuroscience Letters.

[11]  S. Amor,et al.  Preactive lesions in multiple sclerosis , 2009, Current opinion in neurology.

[12]  C. A. Foster,et al.  FTY720 Rescue Therapy in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis: Expression of Central Nervous System Genes and Reversal of Blood‐Brain‐Barrier Damage , 2009, Brain pathology.

[13]  Hans Lassmann,et al.  The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.

[14]  Alex Rovira,et al.  MR in the diagnosis and monitoring of multiple sclerosis: an overview. , 2008, European journal of radiology.

[15]  S. Jalkanen,et al.  Vascular adhesion protein‐1 in human ischaemic stroke , 2008, Neuropathology and applied neurobiology.

[16]  M. Linnik,et al.  Anti-Inflammatory Effects of LJP 1586 [Z-3-Fluoro-2-(4-methoxybenzyl)allylamine Hydrochloride], an Amine-Based Inhibitor of Semicarbazide-Sensitive Amine Oxidase Activity , 2008, Journal of Pharmacology and Experimental Therapeutics.

[17]  L. Salter-Cid,et al.  Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis , 2007, Journal of Neural Transmission.

[18]  W. Brück,et al.  A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. , 2006, Brain : a journal of neurology.

[19]  I. Elovaara,et al.  Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis , 2006, Journal of Neuroimmunology.

[20]  J. Szepietowski,et al.  Expression of Vascular Adhesion Protein-1 in Atopic Eczema , 2006, International Archives of Allergy and Immunology.

[21]  S. Jalkanen,et al.  Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. , 2005, The American journal of pathology.

[22]  Alireza Minagar,et al.  Blood-brain barrier disruption in multiple sclerosis , 2003, Multiple sclerosis.

[23]  H. Lassmann,et al.  A comparative analysis of B cell‐mediated myelin oligodendrocyte glycoprotein‐experimental autoimmune encephalomyelitis pathogenesis in B cell‐deficient mice reveals an effect on demyelination , 2002, European journal of immunology.

[24]  Michael J. Ramsbottom,et al.  Critical role of antigen‐specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein , 2002, European journal of immunology.

[25]  S. Jalkanen,et al.  VAP-1: an adhesin and an enzyme. , 2001, Trends in immunology.

[26]  A. Cross,et al.  B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide , 1999, European journal of immunology.

[27]  J. Lizcano,et al.  Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues: biochemical and immunohistological characterization , 1998, Neurochemistry International.

[28]  D. Adams,et al.  Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. , 1998, Journal of immunology.

[29]  B. Engelhardt,et al.  E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. , 1997, Blood.

[30]  S. Jalkanen,et al.  Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein‐1 (VAP‐1) , 1996, European journal of immunology.

[31]  T. Springer,et al.  High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. , 1995, Immunology today.

[32]  V. Perry,et al.  Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Guérin , 1995, Neuroscience.

[33]  T. Carlos,et al.  Leukocyte-endothelial adhesion molecules. , 1994, Blood.

[34]  S. Jalkanen,et al.  Induction and function of vascular adhesion protein-1 at sites of inflammation , 1993, The Journal of experimental medicine.

[35]  V. Vetvicka,et al.  CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions , 1993, Clinical and experimental immunology.

[36]  S. Jalkanen,et al.  A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. , 1992, Science.

[37]  M. Kadin,et al.  Improved detection of lymphoid cell surface antigens in tissues fixed in periodate-lysine-paraformaldehyde (PLP). , 1987, American journal of clinical pathology.

[38]  S. Jalkanen,et al.  Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. , 2005, Immunity.